Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

AMG 714 20060349 Multiple Dose Study in Moderate to Severe Psoriasis Subjects

This study has been completed.
Information provided by (Responsible Party):
Amgen Identifier:
First received: March 1, 2007
Last updated: December 16, 2015
Last verified: December 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2010
  Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: December 16, 2015